Drug Rehab Archives - Detox Treatment

Drug Rehab November 19, 2018January 4, 2019

Learning More About Drug Rehab

Drug rehab is fundamental for anyone with a substance dependency problem. The journey to sobriety is not a one day event but a series of…

Mayor vapeo, consumo de marihuana en 2019 entre jóvenes de edad universitaria
Los aumentos se encuentran entre los más altos registrados en la historia de la encuesta nacional
Un novedoso antagonista del receptor de dopamina D3 reduce comportamientos similares a la adicción a los opioides en las ratas
El antagonista VK4-116 del receptor de dopamina D3 redujo la autoadministración de oxicodona en las ratas, así como los comportamientos de búsqueda de drogas tras la reanudación del uso de oxicodona después de la abstinencia.
Neighborhood conditions associated with children’s cognitive function
NIH-funded research from ABCD Study finds association despite household income
Parte 2: Inmunoterapias: ¿Una nueva herramienta para tratar la adicción a la metanfetamina?
Los investigadores trasladan su anticuerpo monoclonal a ensayos clínicos para ver si puede ser un tratamiento eficaz para el uso de metanfetamina.
Amy Hauck Newman appointed to lead NIDA’s Intramural Research Program
Dr. Newman officially began her new position at the NIDA IRP on November 22, 2020
NIH study tests a comprehensive model intervention to reduce opioid overdose deaths in hard-hit communities
COVID-19 brings challenges, learning opportunities
NIH-funded study links adolescent brain differences to increased waist circumference
Finding from ABCD Study elucidates neural mechanisms that may underlie early weight gain
Parte 1: Inmunoterapias: ¿Una nueva herramienta para tratar la adicción a la metanfetamina?
Los investigadores tienen creado un anticuerpo monoclonal destinado a interactuar con la metanfetamina y disminuir su capacidad de ingresar al cerebro.
Narrative of Discovery: The Quest for a Medication to Treat Methamphetamine Addiction, Part 5
In the summer of 2019, Dr. Linda Dwoskin and her research team felt they were in a promising place in their decades-long search for a treatment for the 700,000 Americans with methamphetamine use disorder. What she did not anticipate, however, was a storm called COVID-19.
Gaps in substance use treatment services for HIV patients around the globe
Substance use is common among people living with HIV and is associated with less successful HIV treatment outcomes. Integrating substance use services into HIV care is a promising strategy to improve patient outcomes and reduce HIV incidence.